Nearly 1 in 8 Americans have used a GLP-1 drug. As such, their oral health needs increase, yet they aren't always aware of it.
Sponsored ContentSponsored by RAMP Results
According to a 2025 RAND study, nearly 1 in 8 Americans have used a GLP-1 medication. Prescriptions have more than tripled since 2020, and in January 2026, a daily pill version launched, hitting 170,000 new prescriptions in its first three weeks. Furthermore, use is highest among women aged 50 to 64, with 1 in 5 in that group having taken one. That's also one of the highest-value patient groups in dentistry, warranting a marketing strategy tailored to their unique oral healthcare needs.
GLP-1 Side Effects Increase Dental Needs
As with many medications, there are side effects to consider. Regarding oral health, it's common to see that dry mouth accelerates tooth decay and disrupts the oral microbiome in GLP-1 patients. In addition, nausea and acid reflux erode enamel. Appetite suppression also shifts eating toward frequent snacking, changing caries risk in ways most patients haven't been warned about. Furthermore, rapid weight loss can add bone density considerations.
These patients need more dental care than they're getting. However, they might not know it. That's exactly why marketing to them matters.
Target Marketing, Refined
GLP-1 patients don't search for a dentist because of their medication. That's what makes RAMP's approach well-suited to this audience. RAMP's lifestyle targeting reaches people based on their daily habits, health interests, and demographic profile, the exact signals that identify a GLP-1 patient in your area.
Keyword retargeting follows patients who've searched GLP-1-related terms, keeping your practice visible as they browse. And given how much GLP-1 conversation happens on social media, organic and paid social campaigns reach an audience that's already engaged with the topic.
Together, those tools connect your practice with patients who have specific needs. A marketing strategy that speaks to those needs directly positions you as the practice that understands them, and that's a genuine advantage.
Market Now, Win Later
GLP-1 prescribing isn't slowing down anytime soon. Meaning the practices that build a strategy around this patient demographic now will be ahead of the curve.
Schedule a free strategy session with RAMP and find out what a targeted campaign looks like for your practice.
